It appears if you just followed the insiders (Nader, Beshar, Stratemeier) and bought shares when they bought on the open market at $5.36 you would be looking at almost a 600% gain in less than 2 years. Analyze it all you want but the results speak for themselves. It figures since they would know best about the future of the company. Perhaps they were trying to tell the little guy this was the time to buy.
I was a little shocked by the cost of Gattex. I hope NPSP doesn't price themselves out of the US market. It may be a whole lot cheaper to go overseas to get the drug. Does insurance actually pay this......no wonder the US health care system is in turmoil.